Wednesday, October 05, 2016 7:55:20 PM
THE CURRENT BREAD N BUTTER:
Principal Products:
The brand names of the principal products of Trinity Biotech are listed below, organised first by point of use and second by application. The trademarks and registered marks noted below are owned by Trinity Biotech.
Trinity Biotech also sells raw materials to the life sciences industry and research institutes globally through its wholly owned subsidiary, Benen Trading Ltd., trading as Fitzgerald Industries. Trinity Biotech sells its products through its direct sales organisations in the United States, Brazil and to an extent the United Kingdom, and through its network of principal distributors and non-governmental bodies into approximately 100 countries globally.
Point-Of-Care Clinical Laboratory Infectious Diseases Emergency Medicine Infectious Diseases Haemoglobin Autoimmune Clinical Chemistry Blood Bank Screening UniGold™ Meritas Bartels Premier™ ImmuBlot™ EZ™ Captia™ Recombigen MarDx Ultra ImmuGlo™ MicroTrak™ MarBlot ImmuLisa™ OTOblot™
Trinity has also developed a BNP test on the same platform. BNP is a biomarker utilised in aiding the diagnosis of and determining the clinical severity of acute and chronic heart failure. In addition, BNP can be useful in a wide range of clinical applications including risk stratification and monitoring of patients with heart failure and heart attacks. CE marking and EU regulatory approval was received for this product in September 2014. US clinical studies for the product commenced in 2015, and submission to the FDA is anticipated in mid-2016. Once approved, the BNP assay will run side by side, on the same platform as Trinity’s Troponin product. Once the combined product offering is approved for commercialisation, Trinity will be positioned to successfully target and compete in the combined BNP and Troponin point-of-care market. The cardiac point-of-care market is estimated to be US$1 billion per year.
A top priority for Trinity Biotech is to expand its offering on the Meritas POC Analyser. The focus of our development efforts is to continue to expand the test menu to include assays for deep vein thrombosis and pulmonary embolism (D-dimer), and other highly valuable areas of need in emergency medicine. Currently, Trinity Biotech offers the Meritas Troponin and BNP products for sale in Europe and other selected markets through its specialist Cardiology Distributor network. Trinity Biotech will launch the products in the U.S. following FDA clearance.
it sells, just not in the U.S. .... YET!
http://www.trinitybiotech.com/wp-content/uploads/2015/01/Form-20-F-2015.pdf
page 29.
page 30.
SIDEWAYS TRADING IS WAY BETTER THAN THE SLOW BLEED. I'll wait for the pop.
Recent TRIB News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/23/2024 12:11:34 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/20/2024 09:14:54 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/19/2024 10:01:06 AM
- Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer • GlobeNewswire Inc. • 09/18/2024 08:05:07 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/10/2024 02:35:29 PM
- Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology • GlobeNewswire Inc. • 09/09/2024 08:05:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/05/2024 05:26:40 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/05/2024 02:52:57 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/04/2024 03:59:56 PM
- Trinity Biotech Appoints Global Life Sciences Leader as Chief Commercial Officer • GlobeNewswire Inc. • 09/03/2024 01:55:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/29/2024 10:01:30 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/28/2024 09:11:12 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/27/2024 04:33:05 PM
- Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales • GlobeNewswire Inc. • 08/26/2024 08:05:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/21/2024 08:40:05 PM
- Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing Director • GlobeNewswire Inc. • 08/20/2024 09:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/20/2024 05:52:48 PM
- Trinity Biotech Announces Q2 2024 Financial Results • GlobeNewswire Inc. • 08/14/2024 11:30:09 AM
- Trinity Biotech to Announce Q2 2024 Financial Results • GlobeNewswire Inc. • 08/13/2024 08:05:02 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/07/2024 09:27:54 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/07/2024 09:26:45 PM
- Trinity Biotech Obtains an Extension to Demonstrate Compliance With Nasdaq Listing Requirements • GlobeNewswire Inc. • 08/06/2024 08:05:22 PM
- Trinity Biotech Provides Preliminary Second Quarter 2024 Update and Enters into UK Distribution Agreement with MedScience • GlobeNewswire Inc. • 08/02/2024 01:24:23 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/12/2024 09:03:40 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/12/2024 08:53:34 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM